These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35310798)

  • 1. Rapidly progressive glomerulonephritis in children.
    Moorani KN; Aziz M; Amanullah F
    Pak J Med Sci; 2022 Jan; 38(2):417-425. PubMed ID: 35310798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
    Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
    Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group.
    Aydin Z; Turkmen K; Dede F; Yasar E; Ozturk S; Aydin M; Tatar E; Sahin G; Manga G; Oto O; Sumnu A; Eroglu E; Dincer T; Dursun B; Eren N; Sevinc M; Guzel FB; Yalin S; Kutlay S; Apaydin S; Berktas HB; Kazan S; Dheir H; Bora F; Basturk T; Sahin I
    Clin Exp Nephrol; 2021 Feb; 25(2):173-183. PubMed ID: 33040246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characteristics and predictors of outcome of rapidly progressive glomerulonephritis: a retrospective study.
    Mohamed ON; Ibrahim SA; Saleh RK; Issa AS; Setouhi A; Rabou AAA; Mohamed MR; Kamel SF
    BMC Nephrol; 2024 Mar; 25(1):103. PubMed ID: 38500101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria.
    Xu PC; Chen T; Gao S; Hu SY; Wei L; Yan TK
    Ren Fail; 2018 Nov; 40(1):554-560. PubMed ID: 30278797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological spectrums and renal prognosis of severe lupus patients with rapidly progressive glomerulonephritis.
    Chen S; Chen H; Liu Z; Zhang H; Hu W; Tang Z; Liu Z
    Rheumatol Int; 2015 Apr; 35(4):709-17. PubMed ID: 25281226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly progressive glomerulonephritis and acute kidney injury associated with cocaine use - Case report.
    Pimentel PVS; Freitas HC; Leite MDB; Lima RSA; Barreto DMS; Teixeira AC; Daher EF
    J Bras Nefrol; 2021; 43(2):283-287. PubMed ID: 32573647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicohistological Profile and Outcomes of Rapidly Progressive Glomerulonephritis: A Prospective Study from North India.
    Sharma D; Mehta S; Sandhu JS; Sohal PM; Makkar V
    Saudi J Kidney Dis Transpl; 2022; 33(1):122-131. PubMed ID: 36647986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis.
    Syed R; Rehman A; Valecha G; El-Sayegh S
    Biomed Res Int; 2015; 2015():402826. PubMed ID: 26688808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge.
    Bell S; Lattanzio N; Abdelal Q; Teklie Y; Alkayali T; Wiese-Rometsch W; Sastry A
    J Investig Med High Impact Case Rep; 2021; 9():23247096211013193. PubMed ID: 33966476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.
    Nakabayashi K; Fujioka Y; Nagasawa T; Kimura T; Kojima K; Arimura Y; Yamada A
    Clin Exp Nephrol; 2011 Apr; 15(2):226-34. PubMed ID: 21246240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis.
    Cheungpasitporn W; Zacharek CC; Fervenza FC; Cornell LD; Sethi S; Herrera Hernandez LP; Nasr SH; Alexander MP
    Clin Kidney J; 2016 Feb; 9(1):97-101. PubMed ID: 26798468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of rapidly progressive glomerulonephritis associated with both antineutrophil cytoplasmic antibody-associated vasculitis and anti-glomerular basement membrane nephritis in the course of nontuberculous mycobacterium infection: a case report.
    Kato M; Wakiya R; Kameda T; Inoue K; Sofue T; Ushio Y; Sugihara K; Nakashima S; Shimada H; Mansour MMF; Kadowaki N; Dobashi H
    BMC Rheumatol; 2020 Dec; 4(1):68. PubMed ID: 33308324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology and outcome of crescentic glomerulonephritis.
    Sinha A; Puri K; Hari P; Dinda AK; Bagga A
    Indian Pediatr; 2013 Mar; 50(3):283-8. PubMed ID: 23024099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
    Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
    J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study.
    Hedger N; Stevens J; Drey N; Walker S; Roderick P
    Nephrol Dial Transplant; 2000 Oct; 15(10):1593-9. PubMed ID: 11007827
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.